Back to WA Weiss Asset Management LP

TBPHTBPH

Showing 8 of 20 quarters

Position history for WAWeiss Asset Management LP's holdings in THERAVANCE BIOPHARMA INC

As of its Q2 2026 13F, Weiss Asset Management held 7,457,060 shares of TBPH (Theravance Biopharma), worth $126.8M. Weiss Asset Management's 13F filings listed TBPH from Q4 2021 to Q2 2026, 19 quarterly filings. TBPH was 1.3% of Weiss Asset Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$70.2M

Total Shares Change

-7.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2026-Q2
Unchanged
7.5M
0.0%
$126.8M1.3%$17.00
0
2026-Q1
Unchanged
7.5M
0.0%
$121M2.0%—
0
2025-Q4
Unchanged
7.5M
0.0%
$139.5M1.8%—
0
2025-Q3
Unchanged
7.5M
0.0%
$108.9M1.3%—
0
2025-Q2
Unchanged
7.5M
0.0%
$82.3M0.9%—
0
2025-Q1
Unchanged
7.5M
0.0%
$66.6M1.3%—
0
2024-Q4
Unchanged
7.5M
0.0%
$70.2M1.3%—
0

Optional analytics helps us improve. How it’s used